News
J.P. Morgan analyst Anupam Rama maintained a Buy rating on AnaptysBio today and set a price target of $80.00. The company’s shares opened today at $28.15. Take advantage of TipRanks Premium at 50% off ...
2d
Investor's Business Daily on MSNAnaptysBio Earns RS Rating Upgrade
In a welcome move, AnaptysBioANAB saw its Relative Strength Rating rise from 61 to 74 on Thursday.Please watch the video at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results